Hallervorden-Spatz Syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
The patient was found to have two mutations in the pantothenate kinase 2 (PANK2) gene that have been previously associated with pantothenate kinase-associated neurodegeneration: a paternally inherited p.G521R and maternally inherited p.T528M.
|
23968566 |
2013 |
Hallervorden-Spatz Syndrome
|
0.800 |
Biomarker
|
disease |
BEFREE |
The influence of iron deposits on T2 values and the content of metabolites in the brain of three patients with DNA proved pantothenate kinase-associated neurodegeneration (PKAN, formerly Hallervorden-Spatz syndrome) was studied.
|
15565311 |
2005 |
Hallervorden-Spatz Syndrome
|
0.800 |
AlteredExpression
|
disease |
BEFREE |
Interestingly, pantothenate supplementation, the substrate of the PANK2 enzyme, corrected all pathophysiological alterations in responder PKAN fibroblasts with low/residual PANK2 enzyme expression.
|
30804242 |
2019 |
Hallervorden-Spatz Syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the PANK2 gene account for the majority of NBIA cases and cause an autosomal recessive inborn error of coenzyme A metabolism called pantothenate kinase-associated neurodegeneration (PKAN).
|
16416393 |
2005 |
Hallervorden-Spatz Syndrome
|
0.800 |
Biomarker
|
disease |
BEFREE |
Pantothenate kinase-associated neurodegeneration (PKAN) is an autosomal recessive neurodegenerative disorder with brain iron accumulation (NBIA).
|
31300018 |
2019 |
Hallervorden-Spatz Syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
All patients with classic Hallervorden-Spatz syndrome and one third of those with atypical disease had PANK2 mutations.
|
12510040 |
2003 |
Hallervorden-Spatz Syndrome
|
0.800 |
Biomarker
|
disease |
BEFREE |
<b>Purpose of the study</b>: Pantothenate Kinase-associated Neurodegeneration (PKAN) is a form of Neurodegeneration with brain iron accumulation (NBIA) due to gene mutations.
|
31738088 |
2019 |
Hallervorden-Spatz Syndrome
|
0.800 |
Biomarker
|
disease |
BEFREE |
Genetic panel for NBIA was ordered, specifically pantothenate kinase-associated neurodegeneration (PKAN), including pantothenate kinase 2 (PanK2) - the genetic marker for the pantothenate kinase enzyme.
|
31431841 |
2019 |
Hallervorden-Spatz Syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Pantothenate kinase-associated neurodegeneration (PKAN) is an autosomal recessive disorder characterized by iron accumulation in the brain, because of mutations in the PANK2 gene.
|
24712887 |
2015 |
Hallervorden-Spatz Syndrome
|
0.800 |
Biomarker
|
disease |
BEFREE |
We report on a patient with late-onset, pantothenate kinase-associated neurodegeneration (PKAN) who revealed two new heterozygous mutations at gene testing and showed asymmetric moderately reduced striatal dopamine transporter binding with single photon emission computed tomography, possibly due to prolonged neuroleptic treatment.
|
16267847 |
2006 |
Hallervorden-Spatz Syndrome
|
0.800 |
Biomarker
|
disease |
BEFREE |
Pantothenate Kinase-Associated Neurodegeneration (PKAN) is a genetic and early-onset neurodegenerative disorder characterized by iron accumulation in the basal ganglia.
|
30141000 |
2019 |
Hallervorden-Spatz Syndrome
|
0.800 |
Biomarker
|
disease |
BEFREE |
This PANK2-caused subgroup of HSS is sometimes referred as PKAN (pantothenate-kinase-associated neurodegeneration).
|
16435199 |
2005 |
Hallervorden-Spatz Syndrome
|
0.800 |
Biomarker
|
disease |
BEFREE |
We exploited the zebrafish model to study the role played by the pank2 gene during embryonic development and get new insight into PKAN pathogenesis.
|
26476142 |
2016 |
Hallervorden-Spatz Syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
This study was conducted to identify the genetic mutations in a Chinese boy with PKAN, and to review all PANK2 mutations reported in Chinese cases with PKAN.
|
30681573 |
2019 |
Hallervorden-Spatz Syndrome
|
0.800 |
Biomarker
|
disease |
BEFREE |
Pantothenate kinase-associated neurodegeneration (PKAN) is a rare genetic disorder characterised by progressive generalised dystonia and brain iron accumulation.
|
31202468 |
2019 |
Hallervorden-Spatz Syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Pantothenate kinase associated neurodegeneration is a hereditary disease that arises from mutations that inactivate the human PANK2 gene.
|
26549575 |
2015 |
Hallervorden-Spatz Syndrome
|
0.800 |
Biomarker
|
disease |
BEFREE |
The most frequently identified MSDs were Pantothenate kinase-associated neurodegeneration (PKAN) with 11 papers describing Parkinsonism, Hereditary hemochromatosis (HH) (7 papers), and Wilson's disease (6 papers).
|
30384510 |
2018 |
Hallervorden-Spatz Syndrome
|
0.800 |
Biomarker
|
disease |
BEFREE |
Acanthocytosis is also found in a smaller percentage of cases with pantothenate kinase-associated neurodegeneration (PKAN) and Huntington's disease-like 2 (HDL2).
|
16003113 |
2005 |
Hallervorden-Spatz Syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Mutations in pantothenate kinase 2 (PANK2) and phospholipase A2 (PLA2G6) cause recessive, childhood-onset extrapyramidal disorders termed pantothenate kinase-associated neurodegeneration (PKAN) and infantile neuroaxonal dystrophy (INAD), respectively.
|
21496576 |
2011 |
Hallervorden-Spatz Syndrome
|
0.800 |
Biomarker
|
disease |
BEFREE |
Pantothenate kinase-associated neurodegeneration (PKAN) causes a progressive generalized dystonia which remains pharmacologically intractable.
|
15852393 |
2005 |
Hallervorden-Spatz Syndrome
|
0.800 |
Biomarker
|
disease |
BEFREE |
A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome.
|
11479594 |
2001 |
Hallervorden-Spatz Syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Using DNA mutation analysis, the authors identified a novel missense mutation (P354L) in exon 4 of the PANK2 gene in an adolescent with classic pantothenate kinase-associated neurodegeneration.
|
18239249 |
2008 |
Hallervorden-Spatz Syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
As far as we are aware, this is the first case of classic PKAN with the specific MRI eye-of-the-tiger pattern not carrying a PANK2 mutation.
|
16149094 |
2006 |
Hallervorden-Spatz Syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Missense PANK2 mutation without "eye of the tiger" sign: MR findings in a large group of patients with pantothenate kinase-associated neurodegeneration (PKAN).
|
22127788 |
2012 |
Hallervorden-Spatz Syndrome
|
0.800 |
Biomarker
|
disease |
BEFREE |
Pantothenate kinase-associated neurodegeneration (PKAN, formerly known as Hallervorden-Spatz syndrome) is a rare but devastating neurodegenerative disorder, resulting from an inherited defect in coenzyme A biosynthesis.
|
15525657 |
2005 |